English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Baylor College of Medicine announces 2025 Alumni Awards honorees
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

American Lung Association launches free support program for people living with pulmonary fibrosis
+ Regulatory
Patient Daily | Aug 29, 2025

COO of PhRMA on 340B program: 'Big, urban hospitals are exploiting 340B'
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Aug 28, 2025

Matt Pierce honored with C. Everett Koop Unsung Heroes Award for tobacco policy work
+ Pharmaceuticals
Patient Daily | Aug 27, 2025

Baylor receives $15 million grant renewal for research on Superfund site impact on pregnancies
+ Pharmaceuticals
Patient Daily | Aug 27, 2025

ACAAI offers guidance on managing persistent fall allergy symptoms
+ Pharmaceuticals
Patient Daily | Aug 27, 2025

Baylor researchers identify biomarker linked to response in ER+ breast cancer treatment

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns